These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date, and reported results Terminated||2005-001775-35||Intravesical instillation of BCG strain RIVM versus TICE for prevention of recurrenec in patients with high-risk papillary superficial carcinomas of the urinary bladder. A randomised phase II clinical...||bad-data|
|Reported results Terminated||2006-002856-14||Randomised, placebo-controlled, three-arm parallel-group, double-blind, multicentre, national clinical phase II study to evaluate the efficacy, safety, and tolerability of intravenous 3 and 6 g/m² tre...||2008-06-20||due-trials|
|Completed, but no date, and reported results||2006-003180-31||Comparative efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukaemia||bad-data|
|Reported results||2007-003591-19||AN OPEN, COMPARATIVE, WITHIN PATIENT CONTROLLED MULTICENTRE STUDY OF REPEATED SUBCUTANEOUS INJECTIONS OF METHOTREXATE 50MG/ML AND 10MG/ML TO COMPARE PATIENT SATISFACTION AND LOCAL TOLERABILITY IN PATI...||2009-02-16||due-trials|
|Not reported Terminated||2007-005916-15||Low dose Urokinase therapy by patients with diabetic foot syndrom and critical limb ischemia versus conventionel standard therapy. A randomised, open, controlled Phase III-study.||2009-05-13||due-trials|
|Reported results||2008-002356-18||Clinical phase III trial to compare Treosulfan-based conditioning therapy with Busulfan-based reduced-intensity conditioning (RIC) prior to allogeneic haematopoietic stem cell transplantation in patie...||2018-01-25||due-trials|
|Reported results||2008-006300-27||Efficacy and safety of recombinant asparaginase in infants (< 1 year) with previously untreated acute lymphoblastic leukaemia - Phase II Clinical Trial -||2011-02-23||due-trials|
|Exempt, with results||2010-020613-91||A randomized, multi-centre, parallel-group, open label, Oncaspar® controlled dose ranging trial of three doses of pegylated recombinant asparaginase in adult patients with newly diagnosed acute lympho...||2013-05-21||not-yet-due|
|Reported results||2012-000222-21||An open-label, randomized, two-period cross-over study of repeated subcutaneous injections of methotrexate 50mg/ml solution either by a pre-filled syringe (reference) or by a disposable pre-filled pen...||2013-05-02||due-trials|
|Ongoing, reported early||2013-003604-39||Clinical phase II trial to describe the safety and efficacy of Treosulfan-based conditioning therapy prior to allogeneic haematopoietic stem cell transplantation in paediatric patients with haematolog...||not-yet-due|
|Ongoing||2013-005508-33||Clinical phase II trial to compare Treosulfan-based conditioning therapy with Busulfan-based conditioning prior to allogeneic haematopoietic stem cell transplantation (HSCT) in paediatric patients wit...||not-yet-due|
|Listed as ongoing, but also has a completion date||2015-002586-39||Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to||2018-06-05||bad-data|